|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable, less allowance for credit losses ($9,256 and $7,200, respectively) | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Deferred taxes on income | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY: | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current portion of long-term debt and finance lease obligations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Term loan, AR securitization facility and finance lease obligations | ||||||||||||||||||||
| Term loan, Senior Secured Notes, AR securitization facility and finance lease obligations | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred stock:1,000,000 preferred shares authorized and 800,000 preferred shares outstanding for both periods | ||||||||||||||||||||
| Voting common stock; 100,000,000 shares authorized; 28,833,743 and 28,747,733 shares issued and outstanding | ||||||||||||||||||||
| Treasury Stock, Value | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Equity attributable to shareholders of the Company | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
